Combined Treatment for Generalized Anxiety Disorder (GAD)

Completed · Phase 2

Conditions studied: Generalized Anxiety Disorder

In brief

The purpose of this study is to conduct a preliminary evaluation of the efficacy of combined medication and psychotherapy for generalized anxiety disorder (GAD). The general goals of the current study are to conduct a late stage treatment development study. The goal of this stage of research is to provide a preliminary answer to the question and to gather data to estimate intervention parameters (e.g., effect size, attrition rates, response rates) that would assist in planning further research.

Key facts

Study ID
NCT00620776
Run by
University of Pennsylvania
People needed
69
Starts
2006-10-01
Expected to finish
2008-03-01
Last updated by the study team
2017-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.